In this special World Theranostics Day episode, Christine VanTimmeren and Dr. Brandon Mancini are joined by Dr. Harshad Kulkarni, Chief Medical Advisor at BAMF Health and a global leader in theranostics, to discuss how this innovative approach is transforming cancer care and beyond.
We break down what theranostics is, how it combines diagnostics and targeted therapy, and why it represents one of the most powerful shifts toward truly personalized medicine. Dr. Kulkarni shares his global experience, insights from early adoption in Europe, and how theranostics is rapidly expanding in the United States.
We also explore the growing pipeline of clinical trials, the role of imaging in selecting the right patients, and how this approach is improving patient outcomes, quality of life, and survival. Finally, we look ahead to the future—where theranostics could extend beyond cancer into diseases like cardiovascular disease, Parkinson's, and more.
00:00 Intro & World Theranostics Day
00:41 What Theranostics Means
02:19 Meet Dr. Harshad Kulkarni
02:54 How Dr. Kulkarni Entered Theranostics
04:20 How Europe Advanced Theranostics Earlier Than the U.S.
08:12 Why Imaging Is Essential to Theranostics
09:59 “See What You Treat, Treat What You See”
12:30 FDA-Approved Theranostics Today
15:59 Beyond Cancer: Alzheimer’s, Cardiology, and More
17:43 Why Theranostics Isn’t Available for Every Cancer Yet
21:46 Real Patient Outcomes & Quality of Life
25:34 What’s Next for Theranostics
27:11 Closing Thoughts & Learn More
Connect with the hosts on LinkedIn
Dr. Brandon Mancini
Christine VanTimmeren
Connect with BAMF Health
Our Website
Our Podcast